The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II part of EORTC study 26101: The sequence of bevacizumab and lomustine in patients with first recurrence of a glioblastoma.
 
Wolfgang Wick
Honoraria - MSD Oncology; Prime Oncology; Roche/Genentech
Consulting or Advisory Role - Celldex; Roche/Genentech
Research Funding - Apogenix (Inst); Boehringer Ingelheim (Inst); Roche (Inst)
 
Roger Stupp
Employment - Celgene (I)
Stock and Other Ownership Interests - Celgene (I)
Consulting or Advisory Role - Celgene (Inst); Debiopharm Group (Inst); Merck KGaA (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); UCB (Inst)
Travel, Accommodations, Expenses - Novocure
 
Thierry Gorlia
No Relationships to Disclose
 
Martin Bendszus
No Relationships to Disclose
 
Felix Sahm
No Relationships to Disclose
 
Jacoline E Bromberg
No Relationships to Disclose
 
Alba Ariela Brandes
Travel, Accommodations, Expenses - Roche/Genentech
 
Maaike J Vos
No Relationships to Disclose
 
Julien Domont
No Relationships to Disclose
 
Ahmed Idbaih
No Relationships to Disclose
 
Jean-Sebastien Frenel
No Relationships to Disclose
 
Paul M. Clement
No Relationships to Disclose
 
Michel Fabbro
Travel, Accommodations, Expenses - Roche
 
Emilie Le Rhun
No Relationships to Disclose
 
François Dubois
No Relationships to Disclose
 
Davide Musmeci
No Relationships to Disclose
 
Michael Platten
Honoraria - Merck; Novartis; Roche/Genentech
Research Funding - Bayer (Inst)
Patents, Royalties, Other Intellectual Property - immatics
 
Vassilis Golfinopoulos
No Relationships to Disclose
 
Martin J. Van Den Bent
Consulting or Advisory Role - Abbvie; Actelion; Amgen; Blue Earth Diagnostics; Bristol-Myers Squibb; Cavion; Celldex; Merck; Novartis; Novocure; Roche
Research Funding - Abbvie (Inst); Roche (Inst)